To test for EAT2 expression, we randomly selected individual CLL cases with low or high SLAMF1 or SLAMF7 receptor expression levels and subjected these to western blot analysis for EAT2 using MEC-1 cells transduced to express EAT2 as positive control. The gene discussed is SH2D1B; the disease is B-cell chronic lymphocytic leukemia.